Nodal and distant metastases in sinonasal mucosal melanoma: A population-based analysis

被引:30
作者
Low, Christopher M. [1 ]
Price, Daniel L. [1 ]
Moore, Eric J. [1 ]
Stokken, Janalee K. [1 ]
Van Abel, Kathryn M. [1 ]
Janus, Jeffrey R. [1 ]
Choby, Garret [1 ]
机构
[1] Mayo Clin, Dept Otolaryngol Head & Neck Surg, Rochester, MN USA
关键词
Sinonasal mucosal melanoma; nasal cavity; paranasal sinuses; Surveillance; Epidemiology; and End Results database; MALIGNANT-MELANOMA; SURVIVAL; EXPERIENCE; NASAL; SINUS;
D O I
10.1002/lary.28065
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis Sinonasal mucosal melanoma (SNMM) is a rare malignant neoplasm. No study to date has analyzed the impact that nodal metastases and distant metastases at diagnosis have on overall survival (OS) and disease-specific survival (DSS). Study Design Retrospective database review. Methods The Surveillance, Epidemiology, and End Results database was queried for cases of SNMM. Descriptive statistics were used analyze patient demographic and clinicopathologic variables. The Kaplan-Meier model was used to analyze survival, and the Cox proportional hazards model was used for multivariate analysis. Results Three hundred twenty-eight cases of SNMM were identified. The most frequent sinonasal anatomic location was the nasal cavity in 279 (73.0%) patients, followed by the maxillary sinus in 60 (15.7%) patients. Regional nodal metastases at diagnosis occurred in 33 (8.6%) patients, whereas distant metastases at diagnosis occurred in 41 (10.7%) patients. Five-year OS was 22.7%, and 5-year DSS was 26.8%. The presence of positive nodes at diagnosis (OS P < .0001, DSS P < .0001), distant metastases at diagnosis (OS P = .0442, DSS P = .0442), primary tumor site (OS P < .0001, DSS P < .0001), and increasing age (OS P = .0012, DSS P = .0016) were found to be significant as negative predictors of OS and DSS. Conclusions SNMM is a rare pathologic entity with a poor prognosis. The presence of nodal and distant metastases at diagnosis are negative prognostic factors in OS and DSS. These factors can be used in the development of new models of risk stratification and to inform treatment strategies and surveillance patterns. Level of Evidence NA Laryngoscope, 130:622-627, 2020
引用
收藏
页码:622 / 627
页数:6
相关论文
共 25 条
[1]   Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis [J].
Ahn, Peter H. ;
Mitra, Nandita ;
Alonso-Basanta, Michelle ;
Palmer, James N. ;
Adappa, Nithin D. ;
O'Malley, Bert W., Jr. ;
Rassekh, Christopher ;
Chalian, Ara ;
Cohen, Roger B. ;
Lin, Alexander .
ACTA ONCOLOGICA, 2016, 55 (9-10) :1107-1114
[2]   Nodal metastasis and elective nodal level treatment in sinonasal small-cell and sinonasal undifferentiated carcinoma: a surveillance, epidemiology and end results analysis [J].
Ahn, Peter H. ;
Mitra, Nandita ;
Alonso-Basanta, Michelle ;
Adappa, Nithin D. ;
Palmer, James N. ;
O'Malley, Bert W. ;
Rassekh, Christopher H. ;
Chalian, Ara ;
Cohen, Roger B. ;
Lin, Alexander .
BRITISH JOURNAL OF RADIOLOGY, 2016, 89 (1058)
[3]   The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging [J].
Amin, Mahul B. ;
Greene, Frederick L. ;
Edge, Stephen B. ;
Compton, Carolyn C. ;
Gershenwald, Jeffrey E. ;
Brookland, Robert K. ;
Meyer, Laura ;
Gress, Donna M. ;
Byrd, David R. ;
Winchester, David P. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) :93-99
[4]   Survival and staging characteristics for non-squamous cell malignancies of the maxillary sinus [J].
Bhattacharyya, N .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (03) :334-337
[5]  
Brandwein MS, 1997, ARCH OTOLARYNGOL, V123, P290
[6]   Experience with mucosal melanoma of the nose and paranasal sinuses [J].
Bridger, AG ;
Smee, D ;
Baldwin, MAR ;
Kwok, B ;
Bridger, GP .
ANZ JOURNAL OF SURGERY, 2005, 75 (04) :192-197
[7]  
Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO
[8]  
2-G
[9]   Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis [J].
D'Angelo, Sandra P. ;
Larkin, James ;
Sosman, Jeffrey A. ;
Lebbe, Celeste ;
Brady, Benjamin ;
Neyns, Bart ;
Schmidt, Henrik ;
Hassel, Jessica C. ;
Hodi, F. Stephen ;
Lorigan, Paul ;
Savage, Kerry J. ;
Miller, Wilson H., Jr. ;
Mohr, Peter ;
Marquez-Rodas, Ivan ;
Charles, Julie ;
Kaatz, Martin ;
Sznol, Mario ;
Weber, Jeffrey S. ;
Shoushtari, Alexander N. ;
Ruisi, Mary ;
Jiang, Joel ;
Wolchok, Jedd D. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (02) :226-+
[10]   Sinonasal melanoma: A clinicopathologic review of 61 cases [J].
Dauer, Eileen H. ;
Lewis, Jean E. ;
Rohlinger, Audrey L. ;
Weaver, Amy L. ;
Olsen, Kerry D. .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2008, 138 (03) :347-352